Real-time observation of the effect of iron on receptormediated endocytosis of transferrin conjugated with quantum dots

Journal of Biomedical Optics

Volumn 15, Issue 4, 2010, Pages

  Zhang, Hai Li ^a   Li, Yong Qiang ^a   Zhang, Ming Zhen ^a   Zhao, Yuan Di ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Deferoxamine; Iron; Quantum dots; Transferrin

Indexed keywords

DEFEROXAMINE; FLUORESCENCE INTENSITIES; HELA CELL; IRON DEFICIENCY; NORMAL STATE; OBSERVATIONAL METHOD; QUANTUM DOT; REAL-TIME OBSERVATION; RECEPTOR-MEDIATED ENDOCYTOSIS; TRANSFERRIN;

FLUORESCENCE; MOLECULAR BIOLOGY; OPTICAL PROPERTIES; QUANTUM THEORY; SEMICONDUCTOR QUANTUM DOTS;

IRON;

IRON; QUANTUM DOT; TRANSFERRIN;

ARTICLE; COMPUTER SYSTEM; DRUG EFFECT; ENDOCYTOSIS; HELA CELL; HUMAN; METHODOLOGY; PHYSIOLOGY; SPECTROFLUOROMETRY;

COMPUTER SYSTEMS; ENDOCYTOSIS; HELA CELLS; HUMANS; IRON; QUANTUM DOTS; SPECTROMETRY, FLUORESCENCE; TRANSFERRIN;

EID: 79952199577     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3465595     Document Type: Article

References (35)

1. N. T. V. Le and D. R. Richardson, "The role of iron in cell cycle progression and the proliferation of neoplastic cells," Biochim. Biophys. Acta 1603(1), 31-46 (2002). (Pubitemid 35257983)
2. S. N. Rubtsova and Y. M. Vasil'ev, "Iron chelator deferoxamine induces epithelial transformation of tumor cells," Dokl. Biol. Sci. 411(1), 517-519 (2006). (Pubitemid 46025464)
3. A. I. Schafer, S. Rabinowe, M. S. Le Boff, K. Bridges, R. G. Cheron, and R. Dluhy, "Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload," Arch. Intern Med. 145(7), 1217-1221 (1985). (Pubitemid 15231908)
4. P. Ponka, C. Beaumont, and D. R. Richardson, "Function and regulation of transferrin and ferritin," Semin Hematol. 35(1), 35-54 (1998). (Pubitemid 28047041)
5. D. R. Richardson and P. Ponka, "The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells," Biochim. Biophys. Acta 1331(1), 1-40 (1997). (Pubitemid 27168147)
6. R. R. Crichton and M. Charloteaux-Wauters, "Iron transport and storage," Eur. J. Biochem. 164(3), 485-506 (1987). (Pubitemid 17072802)
7. E. D. Weinberg, "Iron therapy and cancer," Kidney Int. 55, sl31-s134 (1999).
8. H. Rezazadeh and M. Atha, "Effect of iron overload on the benzoyl peroxide-mediated tumor promotion in mouse skin," Cancer Lett. 126, 135-142 (1998). (Pubitemid 28181596)
9. G. Bhasin, H. Kausar, M. S. Alam, and M. Athar, "Progressive iron overload enhances chemically mediated tumor promotion in murine skin," Arch. Biochem. Biophys. 409, 262-273 (2003). (Pubitemid 36259594)
10. S. Kotamraju, C. R. Cjotambar, S. V. Kalivendi, J. Joseph, and B. Kalyanaraman, "Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: role of oxidant-induced iron signaling in apoptosis," J. Biol. Chem. 277(12), 17179-17187 (2002). (Pubitemid 34967751)
11. K. Murakami, K. Ishida, K. Watakabe, R. Tsubouchi, M. Naruse, and M. Yoshino, "Maltol/iron-mediated apoptosis in HL60 cells: participation of reactive oxygen species," Toxicol. Lett. 161(2), 102-107 (2006). (Pubitemid 41790283)
12. Z. Wei and Y. Zhang, "Experimental study of transferrin receptor molecular imaging in human hepatocellular carcinoma transplanted in nude mice," Zhong Hua Zhong Liu Za Zhi (Chin. J. Oncol.) 28(2), 96-98 (2006).
13. E. H. Morgan and T. C. Appleton, "Autoradiographic localization of 125I-labelled transferrin in rabbit reticulocytes," Nature 223, 1371-1372 (1969).
14. R. Adler, E. Hurwitz, J. R. Wands, M. Sela, and D. Shouval, "Specific targeting of adriamycin conjugates with monoclonal antibodies to hepatoma associated antigens to intrahepatic tumors in athymic mice," Hepatology (Philadelphia, PA, U. S.) 22(5), 1482-1487 (2005).
15. W. Dong, J. Wang, and J. Zhang, "Establishment and application for detection of TfR of rat bone marrow cells by immunocytochemical method," J. Medern Lab. Med. 18(5), 11-12 (2003).
16. R. Sciot, A. C. Paterson, P. Eyken, F. Callea, M. C. Kew, and V. J. Desmet, "Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases," Histopathology 12(1), 53-63 (1988).
17. M. B. Gangloff, C. Lai, D. R. Van Campen, D. D. R. Miller, W. A. Norvell, and R. P. Glahn, "Ferrous iron uptake but not transfer is down-regulated in Caco-2 cells grown in high iron serum-free medium," J. Nutr. 126(12), 3118-3127 (1996). (Pubitemid 27023888)
18. G. Xu, R. Liu, O. Zak, P. Aisen, and M. R. Chance, "Structural allostery and binding of the transferrin receptor complex," Mol. Cell Proteomics 4(12), 1959-1967 (2005). (Pubitemid 41830190)
19. L. Melton, "Imaging: the big picture," Nature 437, 775-779 (2005).
20. W. C. W. Chan, D. J. Maxwell, X. Gao, R. E. Bailey, M. Han, and S. Nie, "Luminescent quantum dots for multiplexed biological detection and imaging," Curr. Opin. Biotechnol. 13(1), 40-46 (2002). (Pubitemid 34146546)
21. W. C. W. Chan and S. Nie, "Quantum dot bioconjugates for ultrasensitive nonisotopic detection," Science 281, 2016-2018 (1998). (Pubitemid 28475486)
22. A. Douplik, A. Zam, R. Hohenstein, A. Kalitzeos, E. Nikenke, and F. Stelzle,"Limitations of cancer margin delineation by means of autofluorescence imaging under conditions of laser surgery," J. Innov. Opt. Health Sci. 1, 45-51 (2010).
23. A. P. Alivisatos, W. Gu, and C. Larabell, "Quantum dots as cellular probes," Annu. Rev. Biomed. Eng. 7, 55-76 (2005). (Pubitemid 41170185)
24. J. H. Wang, H. Q. Wang, H. L. Zhang, X. Q. Li, X. F. Hua, and Y. D. Zhao, "Purification of denatured bovine serum albumin coated CdTe quantum dots for sensitive detection of silver(I) ions," Anal. Bioanal. Chem. 388(4), 969-974 (2007).
25. X. F. Hua, T. C. Liu, Y. C. Cao, B. Liu, H. Q. Wang, J. H. Wang, and Y. D. Zhao, "Characterization of the coupling of quantum dots and immunoglobulin antibodies," Anal. Bioanal. Chem. 386(6), 1665-1671 (2006).
26. H. Q. Wang, T. C. Liu, Y. C. Cao, Z. H. Huang, J. H. Wang, and Y. D. Zhao, "A flow cytometric assay technology based on quantum dotsencoded beads," Anal. Chim. Acta 580(1); 18-23 (2006).
27. H. Q. Wang, H. L. Zhang, X. Q. Li, J. H. Wang, Z. L. Huang, and Y. D. Zhao, "Solubilization and bioconjugation of QDs and their application in cell imaging," J. Biomed. Mater. Res. Part A 86(3), 833-841 (2008).
28. T. C. Liu, J. H. Wang, H. Q. Wang, H. L. Zhang, Z. H. Zhang, X. F. Hua, Y. C. Cao, Y. D. Zhao, and Q. M. Luo, "Bioconjugate recognition molecules to quantum dots as tumor probes," J. Biomed. Mater. Res. Part A 83(4), 1209-1216 (2007).
29. J. H. Ward, J. P. Kushner, and J. Kaplan, "Regulation of HeLa cell transferrin receptors," J. Biol. Chem. 257, 10317-10323 (1982). (Pubitemid 13252233)
30. F. Louache, U. Testa, P. Pelicci, P. Thomopoulos, M. Titeux, and H. Rochant, "Regulation of transferrin receptors in human hematopoietic cell lines," J. Biol. Chem. 259, 11576-11582 (1984). (Pubitemid 14010050)
31. A. Dautry-Varsat, A. Ciechanover, and H. F. Lodish, "pH and the recycling of transferrin during receptor-mediated endocytosis," Proc. Natl. Acad. Sci. U.S.A. 80, 2258-2262 (1983). (Pubitemid 13097167)
32. D. S. Lidke, P. Nagy, R. Heintzmann, D. J. Arndt-Jovin, J. N. Post, H. E. Grecco, E. A. Jares-Erijman, and T. M. Jovin, "Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction," Nat. Biotechnol. 22(2), 198-203 (2004). (Pubitemid 38160535)
33. U. Testa, F. Louache, M. Titeux, P. Thomopoulos, and H. Rochant, "The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines," Br. J. Haematol. 60, 491-502 (1985). (Pubitemid 15032636)
34. B. Vaisman, E. Fibach, and A. M. Konijn, "Utilization of intracellular ferritin iron for hemoglobin synthesis in developing human erythroid precursors," Blood 90(2), 831-838 (1997). (Pubitemid 27299124)
35. E. C. Theil, "Regulation of ferritin and transferrin receptor mRNAs," J. Biol. Chem. 265, 4771-4774 (1990).